Showing results (481-490 of 579) with videos related to
Sort By:
Pageof 58
International Immunopharmacology|January 26, 2023
Methotrexate and Triptolide regulate Notch signaling pathway by targeting the Nedd4-Numb axisQiuyu Wu, Xiangjie Chen, Caixia Qiao, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 1, 2025
Impaired megakaryopoiesis due to aberrant macrophage polarization via BTK/Rap1/NF-κB pathway in sepsis-induced thrombocytopeniaZiyan Zhang, Meng Zhou, Yaqiong Tang, et al.Cancer|June 22, 2019
Individualized prediction of leukemia-free survival after autologous stem cell transplantation in acute myeloid leukemiaRoni Shouval, Myriam Labopin, Norbert C Gorin, et al.Journal of Hematology & Oncology|July 6, 2019
Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMTSimona Piemontese, Ariane Boumendil, Myriam Labopin, et al.Frontiers in Cellular and Infection Microbiology|June 2, 2022
Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning RegimenYuhua Ru, Jinjin Zhu, Tiemei Song, et al.Bone Marrow Transplantation|February 19, 2020
Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomesYuhua Ru, Xiang Zhang, Tiemei Song, et al.Frontiers in Immunology|December 16, 2022
Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phaseQingya Cui, Peiqi Liang, Haiping Dai, et al.Journal of Hematology & Oncology|June 21, 2013
A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trialJian Hou, Xin Du, Jie Jin, et al.Annals of Hematology|June 20, 2024
Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantationXuanqi Cao, Zheng Li, Yanming Zhang, et al.Haematologica|May 2, 2020
Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemiaArnon Nagler, Abraham S Kanate, Myriam Labopin, et al.Pageof 58